Pamidronate Disodium Injection 15?mg × 10 Vials Price comparison

描述

Pamidronate Disodium Injection Description

Product name: Pamidronate disodium for injection
Packing specification: 15mg*10 bottles ? Product dosage form: injection ? Packing unit: box
Approval number: National medicine standard H20093151 ? Drug standard code: 86902066001833
Manufacturer: Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Pamidronate Disodium (pamidronic acid) is a second-generation nitrogen-containing bisphosphonate clinically used to prevent bone loss, treat osteoporosis, Paget’s disease, hypercalcemia of malignancy, and multiple myeloma-related bone disease?patents.google.com+12en.wikipedia.org+12prospectresearchreports.com+12.

This injection contains 15?mg of active compound per vial, intended for intravenous infusion in research settings exploring:

• Bone resorption and metabolism

• Neoplastic bone lesions

• Calcium homeostasis

• Bisphosphonate-related side effects such as osteonecrosis of the jaw and hypocalcemia?

Clinical pharmacokinetics show protein-binding ~54%, renal elimination, and a long half-life (~28?±?7?h), making it suitable for steady-state dosing and mechanistic studies?en.wikipedia.org.

? Product Specifications

?? Mechanism of Action & Key Benefits

• Bone preservation: Inhibits osteoclast-mediated bone resorption, reducing skeletal-related events?.

• Clinical relevance: Doses of 30–90?mg monthly empower research in osteolytic conditions and hypercalcemia studies?.

• Rich pharmacokinetics: High protein binding and renal clearance favor predictable blood levels in models?.

• Side effect profiling: Common adverse reactions include fever, bone pain, hypocalcemia, and gastrointestinal upset—valuable for mechanistic toxicity research?.

? Why Choose This Product?

• Approved and traceable by NMPA

• Pharma-grade single-dose vials for convenient use

• Supports robust research in bone disease, oncology, and metabolism

• Ideal for chronic dosing or pharmacokinetic investigations

? Related Research Products

• Zoledronic Acid Injection (Bisphosphonate)

• Alendronate Sodium for Injection

• Denosumab for Injection (RANKL Inhibitor)

? Summary

Pamidronate Disodium 15?mg Injection by Chengdu Tiantai Shan Pharma is a reliable research-grade tool for bone metabolism, oncology, and calcium homeostasis studies. With high-quality manufacture, clear pharmacokinetic profile, and injectable format, it’s suitable for a variety of lab models.
?? For laboratory research or analytical use only — not for human consumption or therapy.